{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:03:30Z","timestamp":1757700210467,"version":"3.44.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012921","name":"Royal College of Surgeons in Ireland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Gastric atrophy (GA) is a pre-neoplastic condition leading to gastric cancer (GC). Early GA detection is critical for guiding surveillance and preventing advanced GC. Histology is the current gold standard for GA diagnosis, but is considered not cost-effective for routine screening in Western populations. Serological methods offer a potentially affordable alternative. Understanding GA prevalence, symptom impact, and optimal detection strategies in low-risk Western populations is essential before integrating GA screening into GC prevention programs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This systematic review and meta-analysis assessed GA prevalence in Northern and Western European populations. Key outcomes included GA prevalence (any topographical distribution in the stomach and corpus-specific), effects of symptomatology on prevalence, and differences between serological and histological prevalence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-two cross-sectional studies (<jats:italic>n<\/jats:italic>\u2009=\u200962,520) were included; 13 used histology and 9 used serology. Overall GA prevalence of any topographical distribution was 13% (95% confidence interval (CI) 7\u201318%). Histology-based studies reported 21% (95% CI 11\u201330%) versus 5% (95% CI 3\u20137%) by serology.<\/jats:p>\n            <jats:p>Corpus-involving GA had a pooled prevalence of 6% (95% CI 4\u20139%), with histology detecting higher rates (10\u201315%) than serology (4\u20135%).<\/jats:p>\n            <jats:p>In symptomatic populations, GA prevalence rose to 47%, compared to 6\u201310% in asymptomatic groups. Corpus GA reached 20% in symptomatic patients versus 6\u20138% in asymptomatic ones.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>GA, especially corpus-involving GA, is more prevalent in Western and Northern European populations than previously thought. These findings suggest that screening for GA in these populations may be a viable route to increasing early GC detection rates and improving outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12029-025-01291-z","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T05:11:19Z","timestamp":1755580279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Prevalence of Gastric Atrophy in Western and Northern European Populations: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"56","author":[{"given":"Eoghan","family":"Burke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Harkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayilone","family":"Arumugasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"10","key":"1291_CR1","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/jgh3.12810","volume":"6","author":"Y Kodaka","year":"2022","unstructured":"Kodaka Y, Futagami S, Watanabe Y, Shichijo S, Uedo N, Aono H, et al. Determination of gastric atrophy with artificial intelligence compared to the assessments of the modified Kyoto and OLGA classifications. JGH Open. 2022;6(10):704\u201310.","journal-title":"JGH Open"},{"issue":"1","key":"1291_CR2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","volume":"13","author":"P Correa","year":"2012","unstructured":"Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2\u20139.","journal-title":"J Dig Dis"},{"key":"1291_CR3","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1007\/s10620-009-0891-4","volume":"55","author":"A Eshmuratov","year":"2010","unstructured":"Eshmuratov A, Nah JC, Kim N, Lee HS, Lee HE, Lee BH, et al. The correlation of endoscopic and histological diagnosis of gastric atrophy. Dig Dis Sci. 2010;55:1364\u201375.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"1291_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0889-8553(05)70138-2","volume":"29","author":"KE McColl","year":"2000","unstructured":"McColl KE, El-Omar E, Gillen D. Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am. 2000;29(3):687\u2013703.","journal-title":"Gastroenterol Clin North Am"},{"key":"1291_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12393","author":"M Leja","year":"2017","unstructured":"Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, et al. Detection of gastric atrophy by circulating pepsinogens: a comparison of three assays. Helicobacter. 2017. https:\/\/doi.org\/10.1111\/hel.12393.","journal-title":"Helicobacter"},{"key":"1291_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-021-01522-1","author":"JE Wang","year":"2022","unstructured":"Wang JE, Kim SE, Lee BE, Park S, Hwang JH, Huang RJ. The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis. Cancer Causes Control. 2022. https:\/\/doi.org\/10.1007\/s10552-021-01522-1.","journal-title":"Cancer Causes Control"},{"key":"1291_CR7","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.2741\/3320","volume":"14","author":"SM Mbulaiteye","year":"2009","unstructured":"Mbulaiteye SM, Hisada M, El-Omar EM. Helicobacter pylori associated global gastric cancer burden. Front Biosci. 2009;14:1490.","journal-title":"Front Biosci"},{"issue":"04","key":"1291_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/a-0859-1883","volume":"51","author":"P Pimentel-Nunes","year":"2019","unstructured":"Pimentel-Nunes P, Lib\u00e2nio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European society of gastrointestinal endoscopy (ESGE), European helicobacter and microbiota study group (EHMSG), European society of pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(04):365\u201388.","journal-title":"Endoscopy"},{"issue":"4","key":"1291_CR9","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.21873\/anticanres.15645","volume":"42","author":"K Syrj\u00e4nen","year":"2022","unstructured":"Syrj\u00e4nen K. Accuracy of serum biomarker panel (GastroPanel\u00ae) in the diagnosis of atrophic gastritis of the corpus. Systematic review and meta-analysis. Anticancer Res. 2022;42(4):1679\u201396.","journal-title":"Anticancer Res"},{"issue":"9","key":"1291_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/gutjnl-2018-318126","volume":"68","author":"M Banks","year":"2019","unstructured":"Banks M, Graham D, Jansen M, Gotoda T, Coda S, Di Pietro M, et al. British society of gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut. 2019;68(9):1545\u201375.","journal-title":"Gut"},{"key":"1291_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.02.023","author":"DT M\u00fclder","year":"2024","unstructured":"M\u00fclder DT, Hahn AI, Huang RJ, Zhou MJ, Blake B, Omofuma O, et al. Prevalence of gastric precursor lesions in countries with differential gastric cancer burden: a systematic review & meta-analysis. Clin Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.cgh.2024.02.023.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1291_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1\u20139.","journal-title":"Syst Rev"},{"issue":"12","key":"1291_CR13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187\u2013203.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"1291_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/ipd.13224","volume":"35","author":"A Vukovic","year":"2025","unstructured":"Vukovic A, Schmutz KA, Borg-Bartolo R, Cocco F, Rosianu RS, Jorda R, et al. Caries status in 12-year-old children, geographical location and socioeconomic conditions across European countries: a systematic review and meta-analysis. Int J Paediatr Dent. 2025;35(1):201\u201315.","journal-title":"Int J Paediatr Dent"},{"issue":"12","key":"1291_CR15","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/gutjnl-2024-332705","volume":"73","author":"M Leja","year":"2024","unstructured":"Leja M. Where are we with gastric cancer screening in Europe in 2024? Gut. 2024;73(12):2074\u201382.","journal-title":"Gut"},{"issue":"3","key":"1291_CR16","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1291_CR17","unstructured":"Elmagarmid AK, Fedorowicz Z, Hammady H, Ilyas IF, Khabsa M, Ouzzani M. Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews. 2014."},{"key":"1291_CR18","doi-asserted-by":"crossref","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj. 2011;343.","DOI":"10.1136\/bmj.d5928"},{"key":"1291_CR19","unstructured":"Downes M, Brennan M, Williams H, Dean R. Appraisal tool for cross-sectional studies (AXIS). BMJ Open. 2006."},{"issue":"4","key":"1291_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jrsm.1260","volume":"8","author":"R Suurmond","year":"2017","unstructured":"Suurmond R, van Rhee H, Hak T. Introduction, comparison, and validation of meta-essentials: a free and simple tool for meta-analysis. Res Synth Methods. 2017;8(4):537\u201353.","journal-title":"Res Synth Methods"},{"issue":"8","key":"1291_CR21","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/00365521.2021.1929451","volume":"56","author":"P Sipponen","year":"2021","unstructured":"Sipponen P. Prevalence rates of heathy stomach mucosa, chronic non-atrophic and atrophic gastritis in endoscopic biopsies in adults born in Finland in 1890\u20131977. Scand J Gastroenterol. 2021;56(8):874\u201381.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"1291_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.21873\/anticanres.14833","volume":"41","author":"L Paloheimo","year":"2021","unstructured":"Paloheimo L, Tiusanen T, Suovaniemi O, Syrj\u00c4nen K. Serological biomarker test (GastroPanel\u00ae) in the diagnosis of functional gastric disorders, Helicobacter pylori and atrophic gastritis in patients examined for dyspeptic symptoms. Anticancer Res. 2021;41(2):811\u20139.","journal-title":"Anticancer Res"},{"issue":"4","key":"1291_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1136\/gut.46.4.460","volume":"46","author":"A Oksanen","year":"2000","unstructured":"Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut. 2000;46(4):460\u20133.","journal-title":"Gut"},{"issue":"12","key":"1291_CR24","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/00365520310007224","volume":"38","author":"P Sipponen","year":"2003","unstructured":"Sipponen P, Laxen F, Huotari K, H\u00e4rk\u00f6nen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol. 2003;38(12):1209\u201316.","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"1291_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/EDE.0b013e3181a3d5f4","volume":"20","author":"MN Weck","year":"2009","unstructured":"Weck MN, Gao L, Brenner H. Helicobacter pylori infection and chronic atrophic gastritis: associations according to severity of disease. Epidemiology. 2009;20(4):569\u201374.","journal-title":"Epidemiology"},{"issue":"2","key":"1291_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/ijc.2910350206","volume":"35","author":"P Slpponen","year":"1985","unstructured":"Slpponen P, Kekki M, Haapakoski J, Iham\u00e4ki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985;35(2):173\u20137.","journal-title":"Int J Cancer"},{"issue":"6","key":"1291_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/bjc.1996.144","volume":"73","author":"T Knight","year":"1996","unstructured":"Knight T, Wyatt J, Wilson A, Greaves S, Newell D, Hengels K, et al. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high-risk groups. Br J Cancer. 1996;73(6):819\u201324.","journal-title":"Br J Cancer"},{"issue":"9","key":"1291_CR28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3109\/00365521.2010.487918","volume":"45","author":"A Telaranta-Keerie","year":"2010","unstructured":"Telaranta-Keerie A, Kara R, Paloheimo L, H\u00e4rk\u00f6nen M, Sipponen P. Prevalence of undiagnosed advanced atrophic corpus gastritis in Finland: an observational study among 4,256 volunteers without specific complaints. Scand J Gastroenterol. 2010;45(9):1036\u201341.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"1291_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/gut.37.2.199","volume":"37","author":"R Schlemper","year":"1995","unstructured":"Schlemper R, Van der Werf S, Vandenbroucke J, Biemond I, Lamers C. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut. 1995;37(2):199\u2013204.","journal-title":"Gut"},{"issue":"2","key":"1291_CR30","first-page":"119","volume":"2","author":"F Sitas","year":"1993","unstructured":"Sitas F, Smallwood R, Jewell D, Millard P, Newell D, Meuwissen S, et al. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 1993;2(2):119\u201323.","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"2","key":"1291_CR31","first-page":"103","volume":"17","author":"F Potet","year":"1993","unstructured":"Potet F, Florent C, Benhamou E, Cabrieres F, Bommelaer G, Hostein J, et al. Chronic gastritis: prevalence in the French population. CIRIG Gastroent\u00e9rologie clinique et biologique. 1993;17(2):103\u20138.","journal-title":"CIRIG Gastroent\u00e9rologie clinique et biologique"},{"issue":"12","key":"1291_CR32","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1080\/00365520802273025","volume":"43","author":"T Storskrubb","year":"2008","unstructured":"Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol. 2008;43(12):1448\u201355.","journal-title":"Scand J Gastroenterol"},{"key":"1291_CR33","doi-asserted-by":"crossref","unstructured":"Song H, Held M, Sandin S, Rautelin H, Eliasson M, S\u00f6derberg S, et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in Northern Sweden between 1990 and 2009. Clinical gastroenterology and hepatology. 2015;13(9):1592\u2013600. e1.","DOI":"10.1016\/j.cgh.2015.04.001"},{"key":"1291_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12727","author":"N Chapelle","year":"2020","unstructured":"Chapelle N, Petryszyn P, Blin J, Leroy M, Le Berre-Scoul C, Jirka I, et al. A panel of stomach-specific biomarkers (GastroPanel\u00ae) for the diagnosis of atrophic gastritis: a prospective, multicenter study in a low gastric cancer incidence area. Helicobacter. 2020. https:\/\/doi.org\/10.1111\/hel.12727.","journal-title":"Helicobacter"},{"issue":"8","key":"1291_CR35","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/00042737-200608000-00018","volume":"18","author":"A Korstanje","year":"2006","unstructured":"Korstanje A, den Hartog G, Biemond I, Roelandse FW, Souverijn JH, Lamers CB. Role of Helicobacter pylori and autoimmunity in serological atrophic corpus gastritis in a Dutch primary care community. Eur J Gastroenterol Hepatol. 2006;18(8):911\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1291_CR36","doi-asserted-by":"crossref","unstructured":"Lax VPSF, x 000 E 9 K. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scandinavian Journal of Gastroenterology. 2000;35(9):950\u20136.","DOI":"10.1080\/003655200750023011"},{"issue":"8","key":"1291_CR37","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.ejca.2010.12.012","volume":"47","author":"C Den Hoed","year":"2011","unstructured":"Den Hoed C, Van Eijck B, Capelle L, van Dekken H, Biermann K, Siersema P, et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer. 2011;47(8):1211\u20138.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1291_CR38","doi-asserted-by":"publisher","first-page":"S-090","DOI":"10.1016\/S0016-5085(19)37011-8","volume":"156","author":"RN Zuzek","year":"2019","unstructured":"Zuzek RN, Andreasson A, Potter MD, Vieth M, Talley NJ, Walker MM, et al. 438\u2013histological gastritis in a community population\u2013prevalence and associations with symptoms. Gastroenterology. 2019;156(6):S-090-S\u221290.","journal-title":"Gastroenterology"},{"key":"1291_CR39","doi-asserted-by":"crossref","unstructured":"Aine R, Kahar E, Aitokari K, Salminen J, Eklund C, Paloheimo L, et al. Atrophic gastritis (AG) and its clinical sequels among elderly people in Finland and Estonia. A comparative study using GastroPanel and B12-vitamin testing of the residents in assisted-housing facilities. Helicobacter. 2016;21(Suppl 1):95.","DOI":"10.14283\/jarcp.2016.115"},{"issue":"9","key":"1291_CR40","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/00365520802078341","volume":"43","author":"C Lewerin","year":"2008","unstructured":"Lewerin C, Jacobsson S, Lindstedt G, Nilsson-Ehle H. Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy. Scand J Gastroenterol. 2008;43(9):1050\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"1291_CR41","doi-asserted-by":"crossref","unstructured":"Venerito M, Schinkel S, Gatta L, Peitz U, Wex T, Di Mario F, et al. M1695 serum pepsinogens and topography of chronic atrophic gastritis in a population sample referred for endoscopy. Gastroenterology. 2010;138(5):S-400.","DOI":"10.1016\/S0016-5085(10)61838-0"},{"key":"1291_CR42","doi-asserted-by":"crossref","unstructured":"Selgrad M, Bornschein J, Frauenschlaeger K, Malfertheiner P. Sa1963 Identification of individuals at risk for gastric cancer who undergo screening colonoscopy. Gastroenterology. 2015;148(4):S-369.","DOI":"10.1016\/S0016-5085(15)31236-1"},{"key":"1291_CR43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.71768","author":"E Burke","year":"2024","unstructured":"Burke E, Harkins P, Arumugasamy M. Incidence of gastric adenocarcinoma in those with gastric atrophy: a systematic review. Cureus. 2024. https:\/\/doi.org\/10.7759\/cureus.71768.","journal-title":"Cureus"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01291-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01291-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T16:47:31Z","timestamp":1757436451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01291-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01291-z","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"25 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}